Drug Type Small molecule drug |
Synonyms BPI 452080, BPI-452080, BPI452080 |
Target |
Action inhibitors |
Mechanism HIF-2α inhibitors(Endothelial PAS domain-containing protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Renal Cell Carcinoma | Phase 1 | China | 28 Apr 2023 | |
Von Hippel-Lindau Disease | Phase 1 | China | 28 Apr 2023 |